Lazard Asset Management LLC Dynavax Technologies Corp Transaction History

Lazard Asset Management LLC

  • $68.3 Billion
  • Q3 2024

A detailed history of Lazard Asset Management LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Lazard Asset Management LLC holds 67,960 shares of DVAX stock, worth $864,451. This represents 0.0% of its overall portfolio holdings.

Number of Shares
67,960
Holding current value
$864,451
% of portfolio
0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$10.05 - $11.61 $682,998 - $789,015
67,960 New
67,960 $757,000
Q1 2024

May 14, 2024
SELL
$11.7 - $14.98 $1.56 Million - $1.99 Million
-133,041 Reduced 59.45%
90,761 $1.13 Million
Q4 2023

Feb 14, 2024
SELL
$13.09 - $14.98 $1.11 Million - $1.27 Million
-84,991 Reduced 27.52%
223,802 $3.13 Million
Q3 2023

Nov 14, 2023
SELL
$12.64 - $14.99 $920,508 - $1.09 Million
-72,825 Reduced 19.08%
308,793 $4.56 Million
Q2 2023

Aug 14, 2023
SELL
$9.85 - $13.17 $696,877 - $931,764
-70,749 Reduced 15.64%
381,618 $4.93 Million
Q1 2023

May 15, 2023
SELL
$9.44 - $11.88 $745,457 - $938,139
-78,968 Reduced 14.86%
452,367 $4.44 Million
Q4 2022

Feb 14, 2023
BUY
$10.27 - $13.29 $5.35 Million - $6.92 Million
520,759 Added 4923.97%
531,335 $5.65 Million
Q3 2022

Nov 14, 2022
SELL
$9.93 - $17.44 $73,392 - $128,899
-7,391 Reduced 41.14%
10,576 $110,000
Q2 2022

Aug 09, 2022
SELL
$7.45 - $12.83 $581,181 - $1 Million
-78,011 Reduced 81.28%
17,967 $226,000
Q1 2022

May 13, 2022
BUY
$9.75 - $14.44 $435,903 - $645,583
44,708 Added 87.2%
95,978 $1.04 Million
Q4 2021

Feb 09, 2022
BUY
$13.17 - $20.94 $675,225 - $1.07 Million
51,270 New
51,270 $721,000
Q3 2021

Nov 15, 2021
SELL
$9.16 - $19.83 $46,862 - $101,450
-5,116 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$7.25 - $10.99 $37,091 - $56,224
5,116 New
5,116 $50,000
Q3 2020

Nov 13, 2020
SELL
$4.32 - $11.7 $72,636 - $196,723
-16,814 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$2.94 - $9.1 $49,433 - $153,007
16,814 New
16,814 $149,000
Q1 2020

May 14, 2020
SELL
$2.27 - $6.2 $15,268 - $41,701
-6,726 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$3.46 - $6.93 $23,271 - $46,611
6,726 New
6,726 $38,000
Q1 2018

May 14, 2018
SELL
$14.65 - $19.9 $268,856 - $365,204
-18,352 Closed
0 $0
Q4 2017

Feb 13, 2018
BUY
$17.3 - $24.08 $317,489 - $441,916
18,352
18,352 $343,000

Others Institutions Holding DVAX

# of Institutions
275
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.61B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email